Inhibikase Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference
BOSTON and ATLANTA, May 4, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and…
Comments Off on Inhibikase Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference